1. Metastasis of genitourinary tumors to the head and neck region
- Author
-
C. Head, Ore Ogunyemi, Khashayar Hematpour, Carol J. Bennett, A. Rojas, and David S. Rogers
- Subjects
Male ,Oncology ,medicine.medical_specialty ,Time Factors ,Neurosurgery ,California ,Metastasis ,Prostate cancer ,Transitional cell carcinoma ,Renal cell carcinoma ,Internal medicine ,Medicine & Public Health ,medicine ,Carcinoma ,Humans ,Carcinoma of the prostate ,Carcinoma, Renal Cell ,Aged ,Neoplasm Staging ,Retrospective Studies ,Aged, 80 and over ,Carcinoma, Transitional Cell ,business.industry ,Incidence ,Genitourinary tumors ,Head and neck cancer ,Prostatic Neoplasms ,Cancer ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Urinary Bladder Neoplasms ,Otorhinolaryngology ,Head and Neck Neoplasms ,Head and Neck Surgery ,Female ,business ,Urogenital Neoplasms ,Follow-Up Studies ,Head and Neck - Abstract
The objective of the present study is to characterize genitourinary tumors (GU) metastatic to the head and neck and to determine long-term prognoses. Using a retrospective chart review of 734 patients treated between January 1995 and May 2005 with an ICD-9 code pertaining to a metastatic head and neck cancer, we found 37 patients with primary GU tumors. There were 24 cases of prostate cancer, 10 cases of renal cell carcinoma, and 4 cases of transitional cell carcinoma. Sixteen of 24 patients (67%) with prostate cancer had a cranial metastasis while 6 of 9 (67%) patients with renal cell carcinoma had cerebral metastasis. We concluded that prolonged survival is possible in prostate cancer patients treated aggressively with radiation and chemotherapy, indicating that early detection and aggressive screening are important in these patients.
- Published
- 2009
- Full Text
- View/download PDF